Categories
- About MIMS Ireland
- New Products
- New Presentations
- New this Month
- Discontinued Products
- New Clinical Evidence
- Clinical Specials
- Irish Medicines Board
- Medicines and Sport
Archives
- December 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
- January 2008
- November 2007
- October 2007
Tagcloud
ACE inhibitor, acetylcholinesterase inhibitor, aciclovir, acne, acute coronary syndrome, acute lymphoblastic leukaemia, ADHD, advanced prostate cancer, advanced renal cell carcinoma, advanced soft tissue sarcoma, adverse reaction, agomelatine, agoraphobia, alendronic acid, alfuzosin, algorithm, aliskiren, allergic rhinitis, allopurinol, alpha1-proteinase inhibitor, Alzheimer's, amantadine hydrochloride, ambrisentan, aminosalicylate, amlodipine, amoxicillin, anaemia, angina pectoris, anidulafungin, ankylosing spondylitis, anti-doping, anti-heparin, anti-human thymocyte immunoglobulin, antibacterial, antibiotic, anticoagulant, antidepressant, antineoplastic, antipsychotic, antiretroviral, antiretroviral therapy, anxiety, aromatase inhibitor, asthma, atazanavir, azacitidine, bacterial infections, BCG Vaccine, beclometasone, behaviour disorders, betamethasone, bevacizumab, bicalutamide, bipolar disorder, bisoprolol fumarate, bisphosphonates, black patients, bladder cancer, bowel cleansing, BPH, breakthrough pain, breast cancer, brinzolamide, bronchospasm, budesonide, bulimia nervosa, calcipotriol, calcium, candesartan, Candida albicans, candidiasis, carbetocin, carbidopa, cardiac insufficiency, cardiovascular disease, cefaclor, ceftriaxone, cefuroxime, cephalosporin, cetirizine, CHF, cholecalciferol, chronic constipation, chronic heart failure, Chronic Kidney Disease, chronic myeloid leukaemia, chronic myelomonocytic leukaemia, chronic pain, chronic pulmonary infection, ciprofloxacin, citalopram hydrobromide, clarithromycin, clavulanic acid, clopidogrel, clotrimazole, clozapine, colorectal cancer, contraception, COPD, coronary artery disease, Crohn’s Disease, cystic fibrosis, dabigatran etexilate, daptomycin, darunavir, dasatinib, degarelix, dementia, depression, dermatophytes, dermatophytose, desogestrel, diabetes, diclofenac, dienogest, diphteria, discontinuations, domperidone, donepezil, doxazosin, doxycycline, drospirenone, duodenal ulcer, dyslipidaemia, eczema, eletriptan, emetogenic cancer chemotherapy, enalapril, endocarditis, entacapone, epigastric bloating, epilepsy, epirubicin, epoetin, ErbB2 (HR2) receptors, erythropoiesis-stimulating agents, esomeprazole, estradiol, ethinylestradiol, etravirine, everolimus, exemestane, faecal impaction, famciclovir, fentanyl, fesoterodine, fever, filgrastim, finasteride, fluconazole, fluoxetine, flurbiprofen, fluvastatin, folate, folic acid, follicular development stimulation, follicular lymphoma, follitropin alpha, fosprepitant, fungal infections, gabapentin, gastric cancer, gastric ulcer, gastroduodenal ulcer, gemcitabine, gestodene, gliclazide, glucosamine sulphate, gonorrhoea, GORD, growth failure, H1N1, hayfever, heart failure, heart rate, Helicobacter pylori, hepatic failure, hepatitis, hepatocellular carcinoma, herpes, hip or knee replacement surgery, hip osteoarthritis, HIV, hyaluronic acid, hydrochlorothiazide, Hylan G-F 20, hypercholesterolaemia, hyperlipidaemia, hyperphosphataemia, hypertension, hyperuricaemia, hypoactive sexual desire disorder, ibritumomab, ibuprofen, IGF-1 deficiency, IMB, immunosuppression, indacaterol, indapamide, infections, inflammation, influenza, insomnia, interferon beta-1a, iobetasol, IOP, ipatropium bromide, irinotecan, Irish Sports Council, ischaemic stroke, isotretinoin, ivabradine, Kaposi's sarcoma, kidney cancer, kidney disease, knee osteoarthritis, lacosamide, lamotrigine, lansoprazole, lapatinib, laropiprant, lenalidomide, lercanidipine, leuprorelin acetate, levodopa, levonorgestrel, liraglutide, lisinopril, losartan, lutropin alpha, Lyme disease, macrogol, magnesium, mania, maraviroc, mecasermin, melatonergic, melatonin, meloxicam, memantine, mesalazine, metastatic colorectal carcinoma, metformin, methadone, methylnaltrexone bromide, methylphenidate hydrochloride, mexiletine hydrochloride, micafungin, migraine, mirtazapine, mixed dyslipidaemia, moxifloxacin, multiple myeloma, multiple sclerosis, muscular disorders, myelodysplastic syndromes, myocardial infarction, naloxone, naratriptan, nasal congestion, nausea, nebivolol, nephropathy, neural tube defects, neutropenia, NICE guidelines, nicotine, nicotinic acid, nilotinib, NSCLC, nutrition, OCD, ocular hypertension, olanzapine, olmesartan, omeprazole, ondensetron, open angle glaucoma, opioid addiction, opioid analgesic, opioid-induced constipation, oseltamivir, osteoarthritis, osteonecrosis of the jaw, osteoporosis, otitis, ovarian cancer, overactive bladder syndrome, oxycodone, paclitaxel, pain, pancreatic cancer, pancreatic exocrine insufficiency, pancreatin, panic disorder, panitumumab, pantoprazole, paracetamol, Parkinson’s, partial-onset seizures, patch, pemetrexed, peptic ulcer, perindopril, peripheral arterial disease, peripheral neuropathic pain, pertussis, piperacillin, Pityriasis versicolor, poliomyelitis, post transplantation hyperlipidaemia, post-operative pain, post-traumatic stress disorder, PPIs, pramipexole, pravastatin, pregnancy, pricing policy, primary hypercholesterolaemia, probiotics, prostate cancer, protamine sulphate, Pseudomonas aeruginosa, psoriasis, psychotic disorders, pulmonary arterial hypertension, pulmonary embolism, quetiapine, raltegravir, ramipril, ranolazine, rasagiline, recombinant IGF-1, reflux oesophagitis, renal disease, renin inhibitor, Restless Legs Syndrome, rheumatoid arthritis, ribavirin, ringworm, risedronate sodium, risperidone, rivaroxaban, rivastigmine, romiplostim, ropinirole, rosacea, RTI, S. aureus, salbutamol, sarcoma, saxagliptin, schizophrenia, SCLC, sertraline, sevelamer carbonate, severe pain, simvastatin, sitagliptin, smoking cessation, sodium alginate, solide organ transplantation, sorafenib, sore throat, spasticity, spinal cord injury, sport, sprain, statins, stroke, strontium ranelate, suicide, systemic embolisation, telmisartan, temsirolimus, terbinafine, testosterone, tetanus, thalidomide, thrombocytopenic purpura, thrush, tibolone, timolol, tinea, tiotropium, tipranavir, tizanidine, tobramycin, tocilizumab, topotecan, trabectedin, tramadol, Trichophyton, trimethoprim, trospium chloride, ustekinumab, UTI, vaccine, valaciclovir, valproate, valsartan, varenicline, venlafaxine, venous thromboembolism, venous thrombosis, vildagliptin, vinorelbine, vitamin D, vomiting, WADA, warfarin, wound, zanamivir, zoledronic acid, Zollinger-Ellison syndrome
MIMS Ireland: January 2010
Bisphosphonates and Osteonecrosis of the Jaw
04 January 2010 | Irish Medicines Board
Risk Minimisation and Recommended Preventative Dental Measures Bisphosphonates are a class of medicines approved for various indications related to their inhibitory effect on bone resorption in certain diseases, including prophylaxis and treatment of osteoporosis; treatment of Paget’s disease; and as... Read more
Caltrate
04 January 2010 | New Products
Company: Wyeth Consumer Healthcare. Legal category: Pharmacy only. GMS. Sport permitted. Active ingredients: Calcium (as carbonate) 600mg, cholecalciferol 10µg (eq. to 400 I.U. vitamin D3). Description: Capsule-shaped grey/beige tablets. One side is scored and engraved with D on the left... Read more
Ciloxan Ear Drops
04 January 2010 | New Products
Company: Alcon Laboratories (UK) Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Ciprofloxacin (HCl) 3mg/ml. Description: Clear, colourless to pale yellow solution. Presentation: 5ml, €4.38. Indication: Acute otitis externa due to susceptible strains of bacterial species shown to be... Read more
Cipralam
04 January 2010 | New Products
Company: Actavis Ireland Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Citalopram (as hydrobromide) 10mg, 20mg. Description: White, circular, biconvex film-coated tablets. 20mg tablet scored on both sides and can be divided into equal halves. Presentation: 10mg-28, € 9.04;... Read more
Combineb
04 January 2010 | New Products
Company: Clonmel Healthcare Ltd. Legal category: Prescription. GMS. Sport restricted -agonists. Active ingredients: Ipratropium bromide (as monohydrate) / salbutamol (as sulphate), 0.5mg/2.5mg per 2.5ml. Description: Colourless nebuliser solution in ampoule. Presentation: 2.5ml-60, €26.40. Indication: Management of bronchospasm in patients suffering... Read more
Donelinn
04 January 2010 | New Products
Company: Helsinn Birex Therapeutics Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Donepezil (HCl) 5mg, 10mg. Description: 5mg: White, round, biconvex film-coated tablets, marked DZ 5 on one side.10mg: Pale yellow, round, biconvex film-coated tablets, marked DZ 10 on... Read more
Grepid
04 January 2010 | New Products
Company: Pinewood Healthcare. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Clopidogrel (as besilate) 75mg. Description: Pink, round, biconvex, film-coated tablets. Presentation: 28, €34.79. Indication: Prevention of atherothrombotic events in adult patients suffering from myocardial infarction (from a few days... Read more
Ipravent
04 January 2010 | New Products
Company: Clonmel Healthcare Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Ipratropium bromide 250µg/1ml. Description: Clear, colourless nebuliser solution. Presentation: 1ml-20, €4.08; 2ml-20, €4.85. Indications: Reversible bronchospasm associated with chronic obstructive pulmonary disease (COPD). With concomitant inhaled β2-agonists, for... Read more
Kyflam
04 January 2010 | New Products
Company: Actavis Ireland Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Diclofenac (K+) 50mg. Description: Reddish brown, circular, biconvex film-coated tablets. Presentation: 56, €6.32. Indications: Short-term treatment of all grades of pain and inflammation in the following acute conditions:... Read more
Lochol
04 January 2010 | New Products
Company: Clonmel Healthcare Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Fluvastatin 20mg, 40mg. Description: 20mg: Size 3, hard capsules with blue cap and white body. 40mg: Size 1, hard capsules with green cap and white body. Presentation: 20mg-28,... Read more
OsvaRen
04 January 2010 | New Products
Company: Fresenius Medical Care Ireland Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredients: Calcium acetate, 435mg (eq. to 110mg calcium), magnesium carbonate, 235mg (eq. to 60mg magnesium). Description: White to yellowish, oblong film-coated tablet with a single score line.... Read more
Renvela
04 January 2010 | New Products
Company: Genzyme Therapeutics. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Sevelamer carbonate 800mg; 2.4g. Description: 800mg: White to off-white tablets. 2.4g: Pale yellow powder for oral suspension. Presentation: 800mg-180, €184.53; 2.4g-60, €184.53. Indications: Control of hyperphosphataemia: In adults receiving... Read more
Thymoglobuline
04 January 2010 | New Products
Company: Genzyme Therapeutics. Legal category: Prescription. Sport permitted. Active ingredient: Rabbit anti-human thymocyte immunoglobulin 25mg (5mg/ml in reconstituted solution). Description: Powder for solution for infusion in vial. Presentation: 25mg-1. Price available on request. Indications: Immunosuppression in solid organ transplantation, in... Read more
Tizaflex
04 January 2010 | New Products
Company: Actavis Ireland Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Tizanidine 2mg, 4mg. Description: White, round tablets. 2mg: Marked N62. 4mg: Scored and marked N63 on the other side. Presentation: 2mg-120, €66.69; 4mg-120, €83.37. Indication: Spasticity associated with... Read more
Valherp
04 January 2010 | New Products
Company: Ergha Healthcare Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Valaciclovir (HCl) 500mg. Description: Creamy, oblong film coated tablets. Presentation: 10, €18.50; 30, €55.49; 42, €77.66. Indications: Treatment of herpes zoster (shingles). Treatment and prevention (suppression) of herpes... Read more
Valotix
04 January 2010 | New Products
Company: Rowex Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Valaciclovir (HCl) 500mg. Description: White to off-white capsule shaped film coated tablets with 500 debossed on one side and plain on the other side. Presentation: 10, €19.14. Indications: In... Read more
Coversyl Arginine Plus 10mg/2.5mg
04 January 2010 | New Presentations
Prescription. GMS. Sport Prohibited Servier Laboratories are delighted to inform you that Coversyl Arginine Plus 10mg/2.5mg is now available for prescription in Ireland. Coversyl Arginine Plus 10mg/2.5mg contains 10mg of perindopril arginine and 2.5mg of indapamide, extending the range and... Read more
New Formulation for Ecalta
04 January 2010 | New Presentations
Hospital. Sport permitted. Pfizer Healthcare Ireland are pleased to announce the launch of Ecalta WFI, a new formulation of Ecalta. This new formulation, which is to be reconstituted with Water For Injections (WFI) will replace the current formulation containing ethanol... Read more
Nebilet Plus
04 January 2010 | New Presentations
Prescription. GMS. Sport Prohibited. A. Menarini Pharmaceuticals wishes to announce the launch of a new product, Nebilet Plus, a combination of nebivolol and hydrochlorothiazide. Nebilet Plus is indicated for the treatment of essential hypertension in patients whose blood pressure is... Read more
World Anti-Doping Agency announces changes to Prohibited List
04 January 2010 | New this Month
The World Anti-Doping Agency (WADA) has issued a new Prohibited List of Substances and Methods which comes into effect on 1 January 2010. Changes to the Prohibited List are as a result of ongoing reviews by the WADA List and... Read more
New indication for Foznol in Chronic Kidney Disease patients not on dialysis
04 January 2010 | New this Month
Shire Pharmaceuticals Ireland Ltd. have announced that they have received local market approval for an extension to the existing indication for Foznol. This licence extension makes Foznol, the non-calcium, non-resin phosphate binder, available to control hyperphosphataemia in chronic kidney disease... Read more
Amendments to Serenace entry
04 January 2010 | New this Month
MIMS Ireland editorial team wishes to notify you of the update of the entry for Serenace (haloperidol) including all Serenace presentations. Serenace is available as capsules (0.5mg), tablets (1.5mg, 5mg, 10mg, 20mg), as an oral solution (2mg/ml) and a solution... Read more
Centyl 2.5mg and Centyl 5.0mg Discontinued February 2010
04 January 2010 | Discontinued Products
Centyl 2.5mg and Centyl 5.0mg Discontinued February 2010 LEO Pharma would like to inform you of their intention to discontinue Plain Centyl 2.5mg and Centyl 5mg from the Irish market in February 2010. This discontinuation is not due to any... Read more
Anti-doping: 2010 Guide for Prescribers
01 January 2010 | Medicines and Sport
Abbreviations TUE Therapeutic Use Exemption ISTUE International Standard for Therapeutic Use Exemptions The World Anti-Doping Code, published by the World Anti-Doping Agency (WADA), harmonises anti-doping regulations across all sports and in all countries. This Code includes a list... Read more
